Takaharu Hino
Senior Director, Regulatory Strategy & Policy, Oncology, Regulatory Affairs Division, R&D AstraZeneca
Seminars
Wednesday 20th May 2026
Navigating Japan’s Regulatory Challenges in CDx Development from A Pharmaceutical Company Perspective: Practical Solutions & Future Directions
9:30 am
- Current situation and challenges of Japan’s regulatory environment for CDx development compare to US/EU
- Case study of alternative diagnostic development based on these challenges
- Proposals for regulatory environment to advance future companion diagnostics development
